Policy & Regulation
Avacta secures FDA clearance for second pre|CISION oncology programme
21 January 2026 - Biopharmaceutical company Avacta Group PLC (AIM: AVCT) announced on Wednesday that it has received clearance from the U.S. Food and Drug Administration of the Investigational New Dru...
LEO Pharma advances delgocitinib cream into phase 3 trial for lichen sclerosus
21 January 2026 - Danish pharmaceutical company LEO Pharma A/S said on Wednesday that it has initiated the phase 3 DELTA CARE 1 trial to evaluate the efficacy and safety of Anzupgo (delgocitinib) crea...
Syngene International and Bristol Myers Squibb extend collaboration to 2035
21 January 2026 - Syngene International, an India-based global contract research, development, and manufacturing organisation (CRDMO), announced on Tuesday that it has extended its long-standing strat...
Rakuten Medical expands academic access to IR700 dye
21 January 2026 - Biotechnology company Rakuten Medical Inc announced on Tuesday that it that it will provide IRDye 700DX N-hydroxy succinimide (NHS) ester (IR700 dye), at an administrative fee-only a...
Insilico Medicine signs co-development collaboration agreement with Hygtia Therapeutics
21 January 2026 - Insilico Medicine (HKEX: 3696), a Hong Kong-based clinical-stage biotechnology company that utilises generative artificial intelligence (AI), announced on Tuesday that it has signed ...
HistoIndex partners Houston Research Institute
21 January 2026 - HistoIndex, a Singapore-based developer of AI-driven digital pathology solutions for chronic liver disease, said on Tuesday that it has formed a strategic partnership with Houston Re...